Posterior Reversible Encephalopathy Syndrome Associated with Oxaliplatin Use for Pancreatic Adenocarcinoma

Posterior Reversible Encephalopathy Syndrome Associated with Oxaliplatin Use for Pancreatic Adenocarcinoma

The posterior reversible encephalopathy syndrome (PRES) was first described by Hinchey’s group in 1996 as a reversible vasogenic brain edema on magnetic resonance imaging (MRI). Hypertension represents the most frequent manifestation associated with PRES. In the present report, we present a patient...

Full description

Bibliographic Details
Main Authors: David G. Symeonidis, Alexandros D. Liatsos, Evridiki K. Mazlimoglou, Eleni C. Geraki, Christos Kosmas
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Case Reports in Oncology
Subjects:
encephalopathy
syndrome
oxaliplatin
pancreas
posterior reversible encephalopathy syndrome
Online Access:https://www.karger.com/Article/FullText/515076

Internet

https://www.karger.com/Article/FullText/515076

Similar Items